Tweet
Does anyone have a clue how to get this program functional on the ubuntu 11.04?
-
-
All I did was download the 64bit version from here. What have you tried, what doesn't work for you? -
CAP3 unable to run on box...
It doesn't work on 11.04 ubuntu...
Have you tried it on that?
I have tried to extract it directly or un tar it...
The command isn't seen....
is their a sudo command?
I tried to ./configure, ./make and ./sudo make...
NO LUCK!!!!
WTF?Comment
-
The download links at the address I posted will give you pre-compiled binaries.
Here are the commands I used
You can then copy that binary to somewhere in your system path, for exampleCode:wget http://seq.cs.iastate.edu/CAP3/cap3.linux.i686_xeon64.tar tar xf cap3.linux.i686_xeon64.tar cd CAP3/ ./cap3
Code:sudo cp cap3 /usr/local/bin/
Comment
-
It works!!!
Thanks so much!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!Comment
-
Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.
The systematic characterization of the human proteome has...07-20-2026, 11:48 AM -
Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
...07-09-2026, 11:10 AM -
Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.
There is no single reason why many patients don’t respond to treatment as expected. Cancer is...07-08-2026, 05:17 AM
Comment